Publication
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial
Journal Paper/Review - Jan 1, 2018
Möbus V, Kurbacher C, Untch M, Konecny G E, Hinke A, Runnebaum I B, von Minckwitz G, Harbeck N, Huober Jens, Schneeweiss A, Nitz U, Kuhn W, Thomssen C, du Bois A, Lück H J, Jackisch C, AGO Breast Study Group (AGO-B)
Möbus, V
9
0
Jackisch, C
17
0
Lück, H J
2
0
du Bois, A
10
0
Thomssen, C
10
0
Kuhn, W
4
0
Nitz, U
4
0
Schneeweiss, A
14
0
Huober, Jens
chief physicianBrustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I
297
12
Harbeck, N
15
0
von Minckwitz, G
14
0
Runnebaum, I B
1
0
Hinke, A
1
0
Konecny, G E
1
0
Untch, M
19
0
Kurbacher, C
1
0
AGO Breast Study Group (AGO-B),
1
0